Stay updated on Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe revision stamp on the page has been updated from v3.6.0 to v3.6.3, indicating a newer release of the ClinicalTrials.gov interface used for the history view.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe recruitment status has changed to 'No longer looking for participants,' indicating enrollment is closed. The record revision version was updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check23 days agoChange DetectedThe revision in the history list advances to v3.5.5, replacing the previous v3.5.4, signaling a newer version of the page has been published.SummaryDifference0.0%

- Check45 days agoChange DetectedA new site revision entry v3.5.4 has been added to the history, and the prior v3.5.3 entry has been removed. This update reflects backend versioning changes without affecting visible studies or data.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page header/footer software revision indicator was updated from **v3.5.0** to **v3.5.3**, reflecting a version change in the ClinicalTrials.gov interface/system.SummaryDifference0.0%

- Check102 days agoChange DetectedThe Record History page shows a new revision label (v3.5.0) and removes the previous revision (v3.4.3), indicating a system version update rather than changes to study content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced Melanoma Clinical Trial page.